Tackling Dengue fever in the era of COVID-19
The London School of Hygiene & Tropical Medicine, the Eijkman Institute for Molecular Biology and PT Astra International Tbk invite you to an exclusive webinar on the topic of Tackling Dengue fever in the era of COVID-19.
Dengue causes the greatest disease burden of any virus transmitted by mosquitoes, ticks or other insects, with an estimated 10,000 deaths and 100 million infections per year, according to the World Health Organization.
A unique collaboration between The Eijkman Institute for Molecular Biology, the London School of Hygiene & Tropical Medicine and PT Astra International Tbk brings together leading scientists in the field of Dengue research to increase our understanding of disease outbreaks in Indonesia and around the world.
We are delighted to invite you to an exclusive webinar to discuss the impact of COVID-19 on Dengue fever diagnostics and treatment. We will be joined by an expert panel who will explore a number of topics including:
- What are the similarities between Dengue and COVID-19 from a clinical and patho-physiological aspect?
- What opportunities may arise from the pandemic that could help tackle Dengue fever in future?
- What advances at a global level are needed to address current gaps in Dengue fever diagnostics and COVID-19, and what is the possible cross-reactivity of antibody diagnosis?
Panel speakers include:
- Professor Martin Hibberd, Professor of Emerging Infectious Diseases, LSHTM
- Mr Joseph Biggs, LSHTM
- Professor David H. Muljono, Professorial Research Fellow, Eijkman Institute Dengue Research Unit
- Dr Tedjo Sasmono, Senior Researcher, Eijkman Institute Dengue Research Unit